DocGo Inc. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
DocGo Inc. (DCGO) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $148.58 thousand as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-08-17
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $148.58K.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $99.65K.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $473.99K.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $1.51M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $148.58K 10-Q · filed 2026-08-17 |
| 2026-03-31 | $99.65K 10-Q · filed 2026-05-11 |
| 2025-09-30 | $473.99K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $1.51M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.25M 10-Q · filed 2025-05-08 |
| 2024-09-30 | $1.00M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.99M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $2.96M 10-Q · filed 2024-05-08 |
| 2023-09-30 | $986.09K 10-Q · filed 2023-11-06 |
| 2023-06-30 | $1.96M 10-Q · filed 2023-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |